135 related articles for article (PubMed ID: 11475437)
1. Similar pro- and anti-inflammatory cytokine production in the different clinical forms of multiple sclerosis.
Durán I; Martínez-Cáceres EM; Brieva L; Tintoré M; Montalban X
Mult Scler; 2001 Jun; 7(3):151-6. PubMed ID: 11475437
[TBL] [Abstract][Full Text] [Related]
2. Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive disease.
Killestein J; Den Drijver BF; Van der Graaff WL; Uitdehaag BM; Polman CH; Van Lier RA
Mult Scler; 2001 Jun; 7(3):145-50. PubMed ID: 11475436
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients.
Nguyen LT; Ramanathan M; Weinstock-Guttman B; Baier M; Brownscheidle C; Jacobs LD
J Neurol Sci; 2003 May; 209(1-2):93-9. PubMed ID: 12686409
[TBL] [Abstract][Full Text] [Related]
4. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
Hamamcioglu K; Reder AT
Mult Scler; 2007 May; 13(4):459-70. PubMed ID: 17463069
[TBL] [Abstract][Full Text] [Related]
5. Leptin enhances the release of cytokines by peripheral blood mononuclear cells from relapsing multiple sclerosis patients.
Frisullo G; Angelucci F; Mirabella M; Caggiula M; Patanella K; Nociti V; Tonali PA; Batocchi AP
J Clin Immunol; 2004 May; 24(3):287-93. PubMed ID: 15114059
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of IL-10 and IL-12p40 in secondary progressive multiple sclerosis.
Soldan SS; Alvarez Retuerto AI; Sicotte NL; Voskuhl RR
J Neuroimmunol; 2004 Jan; 146(1-2):209-15. PubMed ID: 14698865
[TBL] [Abstract][Full Text] [Related]
7. Pattern of cytokine secretion by peripheral blood cells of patients with multiple sclerosis in Brazil.
da Costa P; Yasuda CL; Scagliusi SM; Diaz-Bardales BM; Maciel E; Damasceno BP; Blotta MH; Tilbery CP; Santos LM
Mult Scler; 2000 Oct; 6(5):293-9. PubMed ID: 11064437
[TBL] [Abstract][Full Text] [Related]
8. Defective regulation of IFNgamma and IL-12 by endogenous IL-10 in progressive MS.
Balashov KE; Comabella M; Ohashi T; Khoury SJ; Weiner HL
Neurology; 2000 Jul; 55(2):192-8. PubMed ID: 10908889
[TBL] [Abstract][Full Text] [Related]
9. Effects of combination therapy of beta-interferon 1a and prednisone on serum immunologic markers in patients with multiple sclerosis.
Salama HH; Kolar OJ; Zang YC; Zhang J
Mult Scler; 2003 Feb; 9(1):28-31. PubMed ID: 12617264
[TBL] [Abstract][Full Text] [Related]
10. A clinical and laboratory study evaluating the profile of cytokine levels in relapsing remitting and secondary progressive multiple sclerosis.
Pasquali L; Lucchesi C; Pecori C; Metelli MR; Pellegrini S; Iudice A; Bonuccelli U
J Neuroimmunol; 2015 Jan; 278():53-9. PubMed ID: 25595252
[TBL] [Abstract][Full Text] [Related]
11. The balance of pro-inflammatory and trophic factors in multiple sclerosis patients: effects of acute relapse and immunomodulatory treatment.
Lindquist S; Hassinger S; Lindquist JA; Sailer M
Mult Scler; 2011 Jul; 17(7):851-66. PubMed ID: 21561957
[TBL] [Abstract][Full Text] [Related]
12. Correlation between disease severity and in vitro cytokine production mediated by MSRV (multiple sclerosis associated retroviral element) envelope protein in patients with multiple sclerosis.
Rolland A; Jouvin-Marche E; Saresella M; Ferrante P; Cavaretta R; Créange A; Marche P; Perron H
J Neuroimmunol; 2005 Mar; 160(1-2):195-203. PubMed ID: 15710473
[TBL] [Abstract][Full Text] [Related]
13. Cytokine profile, Foxp3 and nuclear factor-kB ligand levels in multiple sclerosis subtypes.
Alatab S; Maghbooli Z; Hossein-Nezhad A; Khosrofar M; Mokhtari F
Minerva Med; 2011 Dec; 102(6):461-8. PubMed ID: 22193377
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
Obradović D; Kataranovski M; Dincić E; Obradović S; Colić M
Vojnosanit Pregl; 2012 Feb; 69(2):151-6. PubMed ID: 22500369
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis-associated retroviral agent (MSRV)-stimulated cytokine production in patients with relapsing-remitting multiple sclerosis.
Saresella M; Rolland A; Marventano I; Cavarretta R; Caputo D; Marche P; Perron H; Clerici M
Mult Scler; 2009 Apr; 15(4):443-7. PubMed ID: 19251836
[TBL] [Abstract][Full Text] [Related]
16. Immunological profile of patients with primary progressive multiple sclerosis. Expression of adhesion molecules.
Durán I; Martínez-Cáceres EM; Río J; Barberà N; Marzo ME; Montalban X
Brain; 1999 Dec; 122 ( Pt 12)():2297-307. PubMed ID: 10581223
[TBL] [Abstract][Full Text] [Related]
17. Interferon gamma production in blood lymphocytes correlates with disability score in multiple sclerosis patients.
Petereit HF; Richter N; Pukrop R; Bamborschke S
Mult Scler; 2000 Feb; 6(1):19-23. PubMed ID: 10694841
[TBL] [Abstract][Full Text] [Related]
18. Cytokine Profile in Patients with Progressive Multiple Sclerosis and Its Association with Disease Progression and Disability.
Kallaur AP; Oliveira SR; Simão ANC; Alfieri DF; Flauzino T; Lopes J; de Carvalho Jennings Pereira WL; de Meleck Proença C; Borelli SD; Kaimen-Maciel DR; Maes M; Reiche EMV
Mol Neurobiol; 2017 May; 54(4):2950-2960. PubMed ID: 27023227
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of interferon-β1b on cytokine patterns of CD4+ and CD8+ T cells derived from RRMS and PPMS patients.
Skrzipek S; Vogelgesang A; Bröker BM; Dressel A
Mult Scler; 2012 May; 18(5):674-8. PubMed ID: 22025329
[TBL] [Abstract][Full Text] [Related]
20. [CD40L expression on T CD4+ lymphocytes from peripheral blood in patients with relapsing-remitting and secondary progressive multiple sclerosis].
Bilińska M; Frydecka I; Kosmaczewska A; Ciszak L; Koszewicz M; Pokryszko-Dragan A
Pol Merkur Lekarski; 2006 Jan; 20(115):41-5. PubMed ID: 16617733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
